Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 known ✓ | P47900 | 1/20 | 0.61 |
| ▸ | P2RY12 known ✓ | Q9H244 | 1/20 | 0.61 |
| ▸ | IMPDH2 known ✓ | P12268 | 4/20 | 0.61 |
| ▸ | IMPDH1 known ✓ | P20839 | 1/20 | 0.61 |
| ▸ | NT5E | P21589 | 1/20 | 0.74 |
| ▸ | TGM2 | P21980 | 1/20 | 0.73 |
| ▸ | KRAS | P01116 | 4/20 | 0.65 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.64 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.63 |
| ▸ | HINT1 | P49773 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL30173181 | 0.99 | NT5E (0.73) | NT5ETGM2KRASFUT5DCPS | |
| Gtp SCHEMBL9113739 | 0.98 | NT5E (0.72) | NT5ETGM2KRASFUT5DCPS | |
| SCHEMBL28850748 | 0.98 | NT5E (0.72) | NT5ETGM2KRASFUT5DCPS | |
| SCHEMBL1096046 | 0.95 | NT5E (0.73) | NT5ETGM2KRASFUT5DCPS | |
| Gtp SCHEMBL31749625 | 0.93 | NT5E (0.72) | NT5ETGM2KRASFUT5DCPS | |
| Gtp SCHEMBL20578211 | 0.93 | NT5E (0.72) | NT5ETGM2KRASFUT5DCPS | |
| Gtp SCHEMBL2194831 | 0.93 | NT5E (0.71) | NT5ETGM2KRASFUT5DCPS | |
| SCHEMBL28001540 | 0.93 | NT5E (0.71) | NT5ETGM2KRASFUT5DCPS | |
| Gtp SCHEMBL1332521 | 0.93 | NT5E (0.71) | NT5ETGM2KRASFUT5DCPS | |
| E626 SCHEMBL29723939 | 0.93 | NT5E (0.79) | NT5ETGM2KRASFUT5DCPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4526461-A1 | BIOMANUFACTURING OF OLIGOSACCHARIDES AND DERIVATIVES FROM SIMPLE SUGARS | ZYMtronix Catalytic Systems, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| CN-119351436-B | Co-expression recombinant vector, recombinant strain and method for enzymatically synthesizing 6-selenoglutamic acid | 四川大学 | 2025-03-25 | — | — | CN | disclosed |
| CN-119546773-A | Biological production of oligosaccharides and derivatives from monosaccharides | 齐姆特罗尼克斯催化系统股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119351436-A | Co-expression recombinant vector, recombinant strain and method for enzymatically synthesizing 6-selenoglutamic acid | 四川大学 | 2025-01-24 | — | — | CN | disclosed |
| US-20240400604-A1 | NUCLEOSIDE TRIPHOSPHATE PHOTOAFFINITY PROBE, METHOD FOR PREPARING SAME, AND APPLICATIONS THEREOF | SHANDONG UNIVERSITY (CN) | 2024-12-05 | — | — | US | disclosed |
| CN-118001419-A | Self-assembled nano-particle and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-05-10 | — | — | CN | disclosed |
| US-20230407357-A1 | BIOMANUFACTURING OF OLIGOSACCHARIDES AND DERIVATIVES FROM SIMPLE SUGAR | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2023-12-21 | — | — | US | disclosed |
| WO-2023225364-A1 | BIOMANUFACTURING OF OLIGOSACCHARIDES AND DERIVATIVES FROM SIMPLE SUGARS | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| EP-1778854-A1 | METHODS AND COMPOSITIONS FOR PREPARING CAPPED RNA | AMBION, INC. (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006004648-A1 | METHODS AND COMPOSITIONS FOR PREPARING CAPPED RNA | AMBION, INC. (US) | 2006-01-12 | — | — | WO | disclosed |
| US-20050287539-A1 | Methods and compositions for preparing capped RNA | ASURAGEN, INC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400604-A1 | NUCLEOSIDE TRIPHOSPHATE PHOTOAFFINITY PROBE, METHOD FOR PREPARING SAME, AND APPLICATIONS THEREOF | ATIC, PPA1, PNP | P2RY1 78/4885P2RY12 282/4885IMPDH2 640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.